about
Digitoxin and its analogs as novel cancer therapeuticsThe monarch butterfly genome yields insights into long-distance migrationA Screen of FDA-Approved Drugs for Inhibitors of Zika Virus InfectionCrystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabainEvaluating the cancer therapeutic potential of cardiac glycosidesInfluence of Sugar Amine Regiochemistry on Digitoxigenin Neoglycoside Anticancer ActivityInactivation of Src-to-ezrin pathway: a possible mechanism in the ouabain-mediated inhibition of A549 cell migrationEarly downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450Trial watch: Cardiac glycosides and cancer therapyReevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na⁺/K⁺-ATPase α3 subunit-involved mitochondrial stress and amplification of caspase cascadesZebrafish chemical screening reveals the impairment of dopaminergic neuronal survival by cardiac glycosidesDigoxin suppresses HIV-1 replication by altering viral RNA processingOuabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agentsConvallatoxin, a dual inducer of autophagy and apoptosis, inhibits angiogenesis in vitro and in vivoNovel stereoselective bufadienolides reveal new insights into the requirements for Na(+), K(+)-ATPase inhibition by cardiotonic steroidsCardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML)Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia.Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis.Magnesium lithospermate B extracted from Salvia miltiorrhiza elevates intracellular Ca(2+) level in SH-SY5Y cellsDigoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis.Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes.Abnormal expression of ATP1A1 and ATP1A2 in breast cancer.Mining of efficient microbial UDP-glycosyltransferases by motif evolution cross plant kingdom for application in biosynthesis of salidroside.Electronic supplementary materialIdentification of a Na+/K+-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides.Functional drug screening assay reveals potential glioma therapeutics.Cysteine residues 244 and 458-459 within the catalytic subunit of Na,K-ATPase control the enzyme's hydrolytic and signaling function under hypoxic conditions.FXYD6: a novel therapeutic target toward hepatocellular carcinomaElimination of undifferentiated human embryonic stem cells by cardiac glycosides.Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a high-content screen for inducers of autophagyIntracellular calcium regulates nonsense-mediated mRNA decay.Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugsParallel molecular evolution in an herbivore communityInhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells.Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signalingModulation of Na(+)-K(+)-ATPase cell surface abundance through structural determinants on the α1-subunit.Cardenolides of Leptadenia madagascariensis from the Madagascar dry forest.A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides.Modulation of TNF-α mRNA stability by human antigen R and miR181s in sepsis-induced immunoparalysis.A cell-based high-throughput screen addressing 3'UTR-dependent regulation of the MYCN gene.Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
P2860
Q21195743-EDB3F114-3EBF-413B-863D-71BC0BEF0FADQ24633881-874AE7A7-B79E-45CA-804C-15F82A156823Q26252076-A54EC98A-3678-40B7-ACC1-7DF1457D25CEQ27656948-EFD6968A-7B40-424C-96C3-EAAAAC3C3F54Q28386608-F039CB77-96B4-4EA6-956E-093678BE4AE2Q28390870-9418559E-89A8-4216-9E92-E96FF165F480Q28391063-12DE371A-C9DA-4B15-A44F-363B9B58A736Q28395627-47565855-F934-4C11-96EA-706CC7D7A6F3Q28395830-632A148C-0C44-4469-83BE-290E8A959A98Q28397965-50AB1C39-A197-4A28-A7DF-A714A3875D37Q28482588-8FE625DA-E84A-400B-81FC-F96719378255Q28489086-5DC84634-2FF9-4AEB-B63F-194A6636714DQ28534123-C8A62BF8-B63E-4C79-B4BE-03148C71AE7FQ28541345-7D0F1F49-70C2-48AE-A443-4F78B9C9D773Q28831303-9AFA5BA3-0AB6-4A8F-988C-672EECFB4604Q30385919-E03F7C32-E3F0-4F8C-999F-ABFB83432905Q30560419-7E83571A-2E10-4258-9CDE-669E5CEAE192Q33519074-03ED926F-9CEC-4B9C-B152-D027C0901459Q33557904-9479F567-F0C0-4542-B74F-B9E302679A57Q33566322-9EFFBE2D-A31A-4AD6-99B4-114FDC602741Q33648528-2B3441C2-2232-4E77-B985-02FF4D1ADD55Q33672210-EE32358D-98EB-4C38-A538-3D8EECA1C90FQ33673165-04DAEB23-793D-4C23-B6A9-02BDFE957579Q33732721-2F9EB10B-4313-4BA7-B278-AB1C98054432Q33780121-2FA4E2AD-147C-4B5D-88C0-3335FA05A1C8Q33796883-8FE643D7-3A71-42E0-AF03-88E34D1F9941Q33857599-E8DF66F5-FACC-4856-97EA-2DC6B1C9CFB8Q33902853-14AC953D-CFA8-44A0-8B68-4F9DF94A6A47Q33920232-D13579CE-B8A7-4AB2-BB61-5E0590919A5FQ34021019-CE04238D-2688-4DD2-BFF1-A4F130B81EBCQ34286363-FE1A4C77-851A-4684-B000-5B80FD03AB99Q34302452-AA89DD3F-070D-4F31-8A97-C56CA40B6B2AQ34309146-EBEA60C7-6F86-4741-97FE-EBD43BAB6B57Q34500187-6976EEC2-ED1F-458B-9C16-7EBDB4E8EE5CQ34501722-22F831ED-FC4B-4172-8FE2-F37A45D3E1E0Q34504844-9D78C98D-FE32-44CC-B3A9-86341F2B8295Q35052661-1817D700-320A-4A3F-AC4A-6772D668385FQ35084392-FE633F70-6304-420A-A955-0B43A84BF567Q35091119-CDD971FA-DCB4-4C0D-B0D5-6B64A2D95411Q35101095-303FD9A7-7A88-4494-9D49-5DA44972F031
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Novel therapeutic applications of cardiac glycosides.
@ast
Novel therapeutic applications of cardiac glycosides.
@en
Novel therapeutic applications of cardiac glycosides.
@nl
type
label
Novel therapeutic applications of cardiac glycosides.
@ast
Novel therapeutic applications of cardiac glycosides.
@en
Novel therapeutic applications of cardiac glycosides.
@nl
prefLabel
Novel therapeutic applications of cardiac glycosides.
@ast
Novel therapeutic applications of cardiac glycosides.
@en
Novel therapeutic applications of cardiac glycosides.
@nl
P356
P1476
Novel therapeutic applications of cardiac glycosides.
@en
P2093
Ioannis Prassas
P2888
P304
P356
10.1038/NRD2682
P577
2008-10-24T00:00:00Z